Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Cidara Therapeutics Inc CDTX

Healthcare Biotechnology
Cidara Therapeutics, Inc. is a biotechnology company. The Company is developing targeted immunotherapies designed for patients facing serious diseases. The Company’s portfolio comprises various treatment and prevention paradigms, including drug-Fc conjugate (DFC) from its Cloudbreak platform targeting oncologic, viral and autoimmune diseases. The Company is focused on advancing Cloudbreak... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CDTX)

Cidara Therapeutics Announces $105 Million Private Placement

GlobeNewswire 3 days ago

Cidara Therapeutics to Participate in Evercore 7th Annual HealthCONx Conference

GlobeNewswire 5 days ago

Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

GlobeNewswire November 7, 2024

Cidara Therapeutics to Participate in Two Upcoming November Investor Conferences

GlobeNewswire October 31, 2024

Cidara Therapeutics Announces Two Presentations on Drug-Fc Conjugate, CD388, at IDWeek 2024

GlobeNewswire October 16, 2024

Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire October 4, 2024

Cidara Therapeutics Announces Two Presentations on Innovative Drug-Fc Conjugate, CD388, at the 2024 OPTIONS XII for the Control of Influenza Conference

GlobeNewswire September 25, 2024

Cidara Therapeutics Announces First Subjects Dosed in Phase 2b NAVIGATE Trial Evaluating CD388 for the Prevention of Seasonal Influenza

GlobeNewswire September 23, 2024

Cidara Therapeutics Strengthens its Scientific Advisory Board with Infectious Disease Experts

GlobeNewswire September 19, 2024
View More News ››

Opinion & Analysis (NDAQ:CDTX)

BTIG's Hartaj Singh's advice for biotech investors: 'hold your powder' 'til winter

Gail Dutton October 1, 2015

Novel technology platforms with dramatic growth potential: Wedbush's David Nierengarten

George S. Mack August 26, 2015
View More Opinion ››

Bullboard Posts (NDAQ:CDTX)

Cidara Therapeutics Announces $105 Million Private Placement

Breaking News: $CDTX Cidara Therapeutics Announces $105 Million Private PlacementSAN DIEGO, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Cidara...
whytestocks - 3 days ago

Cidara Therapeutics, Inc. (NASDAQ:CDTX): Developing Novel Dr

http://beyondspx.com/2024/08/02/cidara-therapeutics-inc-nasdaqcdtx-developing-novel-drug-fc-conjugate-immunotherapies/
MikeTester - August 3, 2024

Cidara Therapeutics Announces Presentations Highlighting Pha

JUST IN: $CDTX Cidara Therapeutics Announces Presentations Highlighting Phase 1 and Phase 2a Clinical Data on CD388 at ESCMID 2024...
whytestocks - April 26, 2024

Cidara Therapeutics Reacquires Global Development and Commer

BREAKING NEWS: $CDTX Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement...
whytestocks - April 24, 2024

missed this one

another one on my watchlist from last year,but doing  too many other things this month,so glta.
coolfooldumbguy - January 27, 2020

watching this one for

an entry point,so glta.
coolfooldumbguy - September 6, 2019
View more Bullboard ››

Trillion Energy International Inc.

Trillion Energy International Inc.

Trillion Energy International Inc. is a Canada-based oil and gas producing company that strives to maximize shareholder value ...
View More »